FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 83 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,297 | -35.9% | 5,247 | -52.4% | 0.00% | 0.0% |
| Q2 2023 | $36,366 | +213817.6% | 11,020 | +86.1% | 0.00% | 0.0% |
| Q1 2023 | $17 | +30.8% | 5,920 | +224.6% | 0.00% | 0.0% |
| Q4 2022 | $13 | -99.9% | 1,824 | -13.7% | 0.00% | – |
| Q3 2022 | $17,000 | -39.3% | 2,113 | -64.2% | 0.00% | -100.0% |
| Q2 2022 | $28,000 | +75.0% | 5,903 | +789.0% | 0.00% | – |
| Q1 2022 | $16,000 | -75.4% | 664 | -81.7% | 0.00% | -100.0% |
| Q4 2021 | $65,000 | +333.3% | 3,627 | +579.2% | 0.00% | – |
| Q3 2021 | $15,000 | -11.8% | 534 | -67.7% | 0.00% | – |
| Q2 2021 | $17,000 | +41.7% | 1,653 | +62.1% | 0.00% | – |
| Q1 2021 | $12,000 | -80.3% | 1,020 | -80.4% | 0.00% | -100.0% |
| Q4 2020 | $61,000 | -43.0% | 5,199 | -61.6% | 0.00% | +100.0% |
| Q3 2020 | $107,000 | +137.8% | 13,555 | +448.6% | 0.00% | -50.0% |
| Q2 2020 | $45,000 | +650.0% | 2,471 | +165.4% | 0.00% | – |
| Q3 2019 | $6,000 | – | 931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |